IT7924165A0 - 2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito. - Google Patents

2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito.

Info

Publication number
IT7924165A0
IT7924165A0 IT7924165A IT2416579A IT7924165A0 IT 7924165 A0 IT7924165 A0 IT 7924165A0 IT 7924165 A IT7924165 A IT 7924165A IT 2416579 A IT2416579 A IT 2416579A IT 7924165 A0 IT7924165 A0 IT 7924165A0
Authority
IT
Italy
Prior art keywords
benzazepine
tetrahydro
mercapto
substituted
benzazepine mercapto
Prior art date
Application number
IT7924165A
Other languages
English (en)
Other versions
IT1193190B (it
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of IT7924165A0 publication Critical patent/IT7924165A0/it
Application granted granted Critical
Publication of IT1193190B publication Critical patent/IT1193190B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/22Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of halogens; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/022Boron compounds without C-boron linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IT24165/79A 1978-07-07 1979-07-06 2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito IT1193190B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92261378A 1978-07-07 1978-07-07

Publications (2)

Publication Number Publication Date
IT7924165A0 true IT7924165A0 (it) 1979-07-06
IT1193190B IT1193190B (it) 1988-06-02

Family

ID=25447325

Family Applications (1)

Application Number Title Priority Date Filing Date
IT24165/79A IT1193190B (it) 1978-07-07 1979-07-06 2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito

Country Status (24)

Country Link
EP (2) EP0007070B1 (it)
JP (1) JPS5511584A (it)
AR (1) AR222828A1 (it)
AU (1) AU525789B2 (it)
CA (1) CA1115271A (it)
CS (1) CS213381B2 (it)
DD (1) DD147355A5 (it)
DE (1) DE2964530D1 (it)
DK (1) DK156001C (it)
ES (3) ES482281A1 (it)
FI (1) FI67215C (it)
GR (1) GR69675B (it)
HU (1) HU179315B (it)
IE (1) IE48654B1 (it)
IL (1) IL57532A (it)
IT (1) IT1193190B (it)
JO (1) JO1273B1 (it)
NO (1) NO152213C (it)
NZ (1) NZ190745A (it)
PH (1) PH15754A (it)
PL (1) PL216908A1 (it)
PT (1) PT69855A (it)
SU (1) SU1029827A3 (it)
ZA (1) ZA792785B (it)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
US4469634A (en) * 1982-07-29 1984-09-04 Smithkline Beckman Corporation Allyloxy- and allylthio-2,3,4,5-tetrahydro-1H-3-benzazepines
US4652642A (en) * 1984-08-23 1987-03-24 Smithkline Beckman Corporation Azidobenzazepines
US4683229A (en) * 1986-03-17 1987-07-28 Smithkline Beckman Corporation 6-halo-9-alkenyleneoxy-3-alkyl-2,3,4,5-tetrahydro-(1H-3)-benzazepines and their use as selective alpha-adrenergic receptor antagonists
US5942250A (en) * 1986-12-23 1999-08-24 Tristrata Technology, Inc. Compositions and methods for enhancing the topical effects of sunscreen agents
US6384079B1 (en) 1986-12-23 2002-05-07 Tristrata Technology, Incorporated Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
GB9119467D0 (en) * 1991-09-12 1991-10-23 Smithkline Beecham Corp Chemical compounds
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
AP2001002114A0 (en) 1998-10-08 2001-06-30 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents).
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
AU2003273969A1 (en) * 2002-10-07 2004-04-23 Glaxo Group Limited Sulfonamide derivatives as antipsychotic agents
EP2332919A3 (en) 2003-06-17 2011-10-19 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
MXPA05013366A (es) 2003-06-17 2006-04-05 Arena Pharm Inc Derivados de benzazepina utiles para el tratamiento de enfermedades asociadas con el receptor 5ht2c.
EA011011B1 (ru) * 2004-02-25 2008-12-30 Эли Лилли Энд Компани 6-ЗАМЕЩЁННЫЕ 2,3,4,5-ТЕТРАГИДРО-1H-БЕНЗО[d]АЗЕПИНЫ В КАЧЕСТВЕ АГОНИСТОВ РЕЦЕПТОРОВ 5-HT
PT1838677E (pt) 2004-12-21 2009-11-16 Arena Pharm Inc Formas cristalinas do cloridrato de (r)-8-cloro-1-metil- 2,3,4,5-tetra-hidro-1h-3-benzazepina
PT1833473E (pt) 2004-12-23 2009-12-17 Arena Pharm Inc Composições de modulador de receptor 5ht2c e métodos de utilização
EP2518053A1 (en) 2006-04-03 2012-10-31 Arena Pharmaceuticals, Inc. Process for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
WO2008070111A2 (en) 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
EP2288585A1 (en) 2008-03-04 2011-03-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
EP2611782A1 (en) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
NZ630494A (en) 2010-09-01 2016-05-27 Arena Pharm Inc Administration of lorcaserin to individuals with renal impairment
KR20180118801A (ko) 2010-09-01 2018-10-31 에자이 알앤드디 매니지먼트 가부시키가이샤 체중 관리에 유용한 5-ht2c 작동제의 변형-방출 투여 형태
KR20130101524A (ko) 2010-09-01 2013-09-13 아레나 파마슈티칼스, 인크. 5-ht2c 아고니스트의 비-흡습성 염
MX2015004532A (es) 2012-10-09 2016-01-20 Arena Pharm Inc Metodo de control del peso.
CN116655892A (zh) * 2023-05-18 2023-08-29 常州大学 一种交联聚合物有机电极材料及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2520264A (en) * 1947-08-26 1950-08-29 Maltbie Lab Inc Substituted 3, 1-benz-2, 3, 4, 5-tetrahydroazepines
US3483185A (en) * 1966-08-16 1969-12-09 American Home Prod N-substituted 2,3,4,5-tetrahydro-1h-3-benzazepines
GB1268243A (en) * 1968-03-11 1972-03-22 Wallace & Tiernan Inc 0,2,4,5,-tetrahydro-3h,3-benzazepines
US3671519A (en) 1969-07-14 1972-06-20 American Home Prod N-substituted 2,3,4,5,-tetrahydro-1h-3-benzazepines
US3752892A (en) 1970-03-11 1973-08-14 Ciba Geigy Corp Anorexigenic tetrahydrobenzazepine derivative method and composition thereof
US3716639A (en) 1970-03-11 1973-02-13 Ciba Geigy Corp Anorexigenic tetrahydrobenzazepines
US4111957A (en) * 1977-02-02 1978-09-05 Smithkline Corporation Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
US4108989A (en) * 1977-04-01 1978-08-22 Smithkline Corporation 2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diones

Also Published As

Publication number Publication date
AR222828A1 (es) 1981-06-30
DK156001B (da) 1989-06-12
NO152213C (no) 1985-08-28
AU4861379A (en) 1980-02-07
SU1029827A3 (ru) 1983-07-15
IL57532A (en) 1982-08-31
IT1193190B (it) 1988-06-02
IE791276L (en) 1980-01-07
ES482281A1 (es) 1980-04-01
EP0007070B1 (en) 1983-01-19
IL57532A0 (en) 1979-10-31
PL216908A1 (it) 1980-08-11
AU525789B2 (en) 1982-12-02
NO792267L (no) 1980-01-08
DE2964530D1 (en) 1983-02-24
EP0080012B1 (en) 1986-04-09
GR69675B (it) 1982-07-07
CA1115271A (en) 1981-12-29
NZ190745A (en) 1981-01-23
FI67215C (fi) 1985-02-11
PH15754A (en) 1983-03-18
ES482276A1 (es) 1980-04-01
NO152213B (no) 1985-05-13
PT69855A (en) 1979-08-01
ES482282A1 (es) 1980-04-01
IE48654B1 (en) 1985-04-03
FI792125A7 (fi) 1980-01-08
DK278379A (da) 1980-01-08
JPH0153271B2 (it) 1989-11-13
FI67215B (fi) 1984-10-31
EP0007070A1 (en) 1980-01-23
ZA792785B (en) 1980-08-27
HU179315B (en) 1982-09-28
CS213381B2 (en) 1982-04-09
JPS5511584A (en) 1980-01-26
DD147355A5 (de) 1981-04-01
DK156001C (da) 1989-11-06
JO1273B1 (en) 1986-11-30
EP0080012A1 (en) 1983-06-01

Similar Documents

Publication Publication Date Title
IT7924165A0 (it) 2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito.
NL7903029A (nl) 2'deoxy-5-(2-halogeenvinyl)-uridines.
NO153847C (no) 2,4,4-triklor-4-formyl-butyronitril.
IT8119459A0 (it) 25-idrossi-26,26,26,27,27,27-esaflu orocolecalciferolo.
FI812270A7 (fi) Tulehduksenvastaiset 4,5-diaryyli- - polyfluorialkyyli-1H- imidatsoli-2-metaaniamiinit.
FI793261A7 (fi) Farmaseuttinen yhdistelmä, joka sisältää 3,4-dihydro-3-okso-2- kinoksaliineja.
SE7803411L (sv) 2,6-dialkoxibensamider
ATE8631T1 (de) 1,1,1',1'-tetraoxo-penicillanoyloxymethylpenicillanat.
NL7920160A (nl) 24,24-difluor-25-hydroxycholecalciferol.
TR20170A (tr) Mikrobisitler olarak 1,1 difenileten tuerevleri
ATA457479A (de) Stabilisietes 1,1,1-trichloraethan
IT7823796A0 (it) 1,2,4-triazolidin-3-oni e-tioni.
ATA457579A (de) Stabilisiertes 1,1,1-trichloraethan
IT1136980B (it) "17-sostituiti solfonil-16,16-disostituiti androsteni"
NL7901111A (nl) 2,3-dihydro-4h-1-benzopyran-4-on-0-carbamoyloximen.
IT1196913B (it) 6,7 secoergoline
FI791080A7 (fi) 4,6-dihalo-steroidit.
ATE24476T1 (de) 1,3-dihalopropan-2-ole.
FI810242A7 (fi) 1,3-diformyylioksi-2-bromi-2- nitropropaani.
NO153453C (no) Stabilisert 1,1,1-trikloretan.
OA05935A (fr) Egreneuse, EG 78.
DK430479A (da) 2,6-dihalogenbensylestere
FI860774A0 (fi) 3,4,5-trihydroxipiperidinderivat.
NL189460C (nl) 2,6-methano-3-benzazocinederivaat.
IT1209140B (it) 6 alfa-fluoro-prednisolone 17,21-diesteri.